In people with Type 2 diabetes mellitus fasting during Ramadan, use of SGLT-2 inhibitors combined with metformin is as safe, effective and well-tolerated as DPP4 inhibitors combined with metformin. The gene discussed is SLC5A2; the disease is diabetes mellitus.